Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Calcineurin Free Immunosuppression in Renal Transplant Recipients

This study has been completed.
Wyeth is now a wholly owned subsidiary of Pfizer
Information provided by:
University Hospital, Basel, Switzerland Identifier:
First received: December 18, 2008
Last updated: NA
Last verified: December 2008
History: No changes posted
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2005
  Primary Completion Date: July 2005 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):